← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

▼ SELL 10b5-1 Plan

$ Value

$815K

Shares

19,900

Price

$41

Filed

Nov 14

Insider

Name

Ragosa Mark

Title

CHIEF FINANCIAL OFFICER

CIK

0001835458

Roles

Officer

Transaction Details

Transaction Date

2025-11-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

31,086

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $40.93 and $41.035. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | The option is fully vested and exercisable.

Filing Info

Accession No.

0001835458-25-000005

Form Type

4

Issuer CIK

0001730430

Ragosa Mark's History

Date Ticker Type Value
2026-04-07 KNSA M
2026-04-07 KNSA F $64K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $121K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07